Non-GMO, high-protein ‘smart peas’ slated for 2021 debut, with other ‘super trait’ crop varieties to follow

GG June Cover image
Image: Greenhouse Grower

Equinom, an Israeli startup, raised $10 million in a Series B round of funding from BASF Venture Capital, Roquette, Trendlines Group and Fortissimo Capital. The company focuses on non-GMO seed breeding technology to make “smarter seeds.”

Founded in 2012, Equinom focuses on non-GMO seed varieties that have super traits, such as better nutritional profiles. “Equinom’s breeding program designs super-trait seeds on demand. The system determines the varieties and breeding generations needed to obtain the plant seeds defined by food companies. Equinom then breeds the plants naturally and conducts global growing trials to confirm seed viability in multiple cultivation locations,” Equinom said.

The company works with the natural genetic variation among plants to create seeds that are more nutritious and that have higher oil and protein content. Equinom shares that it is already a preferred supplier of sesame seeds. “We also plan to launch our high-protein pea variety in 2021 ….” Gil Shalev, CEO of Equinom, said.

Equinom’s technology optimizes non-GMO seeds to create higher yields, more nutritional value and resistance to disease. The company uses a combination of traditional crossbreeding and computational genetic algorithms to accomplish this. It has also accelerated seed breeding for faster production.

Read the original post

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates ‘skyrocketing’ as RFK, Jr. and MAHA claim? The evidence says mostly the opposite
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.